MAK-SYSTEM International
Paris · Founded 1984
About MAK-SYSTEM International
MAK-SYSTEM provides Web-based software solutions for healthcare organizations in France and internationally. It offers ePROGESA, a solution for the blood banking and blood transfusion activities; and eTRACE LINE, a software solution that safeguards the blood transfusion therapy cycle in hospital transfusion services, blood banks with transfusion centers, and reference labs. MAK-SYSTEM also provides TCS, a software solution for processing tissues, cord blood, and stem cells ranging from collection to transplantation; and ePROGESA for plasma centers to manage various aspects of blood plasma collection activities. Moreover, it offers project management services, such as offsite supervision services; installation services for MAK-SYSTEM software, third party products, and interfaces; training services for super users, IT staff, referent staff, and end users; implementation support services, including hardware configuration, software development, validation, and Go live services; and maintenance services, such as help desk support and patch services. MAK-SYSTEM serves blood banks, transfusion service sectors, cell therapy labs, cord blood banks, transplantation centers, and tissue banks. It began operation in 1984, with its headquarters in Paris in France and additional offices in France, the United States, the United Kingdom, Germany, Macedonia, and Spain.
Company Facts
- Founded: 1984
- Legal name: MAK-SYSTEM International Group
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $10K – $50K
- Funding stage: Private Equity
- Last round: Private Equity (Feb 2020)
- Website: mak-system.com
- Phone: 33 1 44 09 04 04
Social Profiles
Canonical: https://fsome.com/organization/mak-system-international-8378107 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.